Nesrine Sassi

Suita, 5650871, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

Journal: Japanese journal of clinical oncology
Published: May 27, 2026

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

Journal: Japanese journal of clinical oncology
Published: May 11, 2026

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Journal: Scientific reports
Published: April 02, 2026

Microbiome-Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers.

Microbiome-Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers.

Journal: Cancer science
Published: April 01, 2026

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinoma.

Journal: Cancer treatment and research communications
Published: March 26, 2026

SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma.

SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma.

Journal: Anticancer research
Published: December 02, 2025

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Journal: International journal of urology : official journal of the Japanese Urological Association
Published: November 20, 2025

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Journal: BJUI compass
Published: October 16, 2025

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Journal: Cancer science
Published: August 13, 2025

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Journal: Anticancer research
Published: December 20, 2024

Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.

Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.

Journal: Biochemical and biophysical research communications
Published: September 09, 2024

A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.

A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.

Journal: International journal of cancer
Published: August 28, 2024
Showing 1-12 of 16

Last Updated: 09/26/2026